- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
ESCMID calls for universal flu vaccination for healthcare works
4 November 2015 • Author: Victoria White
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) is calling on the healthcare industry to lead by example and implement universal flu vaccination for healthcare workers.
ESCMID is encouraging all health workers to take personal responsibility and get vaccinated this season, particularly those who come into contact with high-risk groups.
Despite free vaccinations for health professionals in many EU countries, it is estimated that only about 30% choose to have the shot despite the carrier risk they present. ESCMID believes that one vital tool to increase the adoption of flu vaccinations among healthcare professionals is to establish hospital-based league tables throughout Europe. The introduction of this policy by European health services is one method the organisation believes will potentially have a transformational effect. It is also in the public interest to give patients valuable information on the level of protection offered in the hospitals they are using to seek treatment.
Highlighting the importance of this issue, Professor Susanna Esposito’s study group – the ESCMID Study Group for Vaccines (EVASG) – is currently working alongside other international groups to research health worker flu vaccination initiatives as part of its comprehensive report on vaccine recommendations.
Flu vaccine “only as good as its uptake”
Professor Susanna Esposito, from the Policlinico hospital at the University of Milan and Head of EVASG, commented, “This year’s flu vaccine is only as good as its uptake. Across Western Europe we have seen varying rates of vaccination among high-risk groups, and we should be looking to raise this further to beyond the 75% coverage mark Europe-wide. What is also underreported is that healthcare professionals who regularly come in contact with vulnerable groups are still seeing, even in overall well-performing countries, maximum rates of only around 1/3 of professionals vaccinated. This is simply not enough; we can clearly do more to prevent the spread of influenza and inform about influenza-related complications.”
Partnering with ESCMID, the European Scientific Working group on Influenza (ESWI) is echoing these calls and lending its support for public hospital flu vaccination rankings. Professor AB Osterhaus, President of ESWI, said: “Certainly, if I was in a vulnerable group – such as older adults, people with heart or respiratory problems, or those with low immunity – and I had a choice of a hospital prior to admission, I would be looking at the vaccination rates in each and pick the hospital with an adequate healthcare professional vaccination policy. It would be reassuring to know they had this extra protection in place.”
Professor Esposito and Professor Osterhaus have suggested that change needs to be twofold on future seasonal influenza outbreaks. Firstly, healthcare professionals need to take a personal responsibility to get themselves vaccinated, especially those working with high-risk groups, as they can easily become viral carriers. But moreover, we need to think about new measures that, while not making vaccination compulsory, do improve its coverage among healthcare professionals.
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd B&W Tek Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited Butterworth Laboratories Ltd CAPSUGEL NV Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) Eurofins BioPharma Product Testing EUROGENTEC F.P.S. Food and Pharma Systems Srl GE Analytical Instruments IDBS JEOL Europe Kaiser Optical Systems Inc. L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited Lonza MA Business Metrohm Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Ocean Optics Panasonic Biomedical Sales Europe B.V. Peak Scientific PerkinElmer Inc ReAgent Russell Finex Limited Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Viavi Solutions, Inc Watson-Marlow Fluid Technology Group Wickham Laboratories Limited Xylem Analytics YMC Europe GmbH Yusen Logistics